Yahoo Web Search

Search results

1. • HC Wainwright Analysts Cut Earnings Estimates for Spruce Biosciences, Inc. (NASDAQ:SPRB)

     ETF DAILY NEWS· 6 days ago

     Spruce Biosciences, Inc. (NASDAQ:SPRB – Free Report) – Equities researchers at HC Wainwright cut their Q2 2024 EPS estimates for Spruce Biosciences in a research note issued ...

2. • Cantor Fitzgerald Comments on Nyxoah S.A.’s FY2024 Earnings (NASDAQ:NYXH)

     ETF DAILY NEWS· 5 days ago

     Nyxoah S.A. (NASDAQ:NYXH – Free Report) – Cantor Fitzgerald upped their FY2024 earnings estimates for Nyxoah in a research note issued to investors on Wednesday, May 15th.

3. • Savara (NASDAQ:SVRA) Price Target Cut to $7.00

     ETF DAILY NEWS· 4 days ago

     Savara (NASDAQ:SVRA – Free Report) had its price objective cut by Evercore ISI from $10.00 to $7.00 in a research note issued to investors on Thursday morning, Benzinga reports ...

4. • TScan Therapeutics (NASDAQ:TCRX) Earns Buy Rating from Analysts at BTIG Research

     ETF DAILY NEWS· 5 days ago

     BTIG Research assumed coverage on shares of TScan Therapeutics (NASDAQ:TCRX – Free Report) in a research note issued to investors on Thursday morning, Marketbeat Ratings reports ...

5. • Truist Financial Reaffirms Buy Rating for Allogene Therapeutics (NASDAQ:ALLO)

     ETF DAILY NEWS· 6 days ago

     Truist Financial restated their buy rating on shares of Allogene Therapeutics (NASDAQ:ALLO – Free Report) in a research note published on Wednesday morning, Benzinga reports ...

6. • 

     PolygenRx Wants to Use Genetics to Guide Chronic Disease Treatments, Starting With Hypertension

     GenomeWeb News· 2 days ago

     Genetics, often typecast as the future of medicine for rare and monogenic conditions, could also be...

7. • Aptose Biosciences (NASDAQ:APTO) Price Target Cut to $6.00

     ETF DAILY NEWS· 6 days ago

     Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) had its price target cut by research analysts at Canaccord Genuity Group from $15.00 to $6.00 in a research note

8. • HC Wainwright Lowers Leap Therapeutics (NASDAQ:LPTX) Price Target to $5.50

     ETF DAILY NEWS· 6 days ago

     Leap Therapeutics (NASDAQ:LPTX – Free Report) had its price objective decreased by HC Wainwright from $7.00 to $5.50 in a research note issued to investors on Tuesday, Benzinga ...

9. • Ascendis Pharma A/S (NASDAQ:ASND) PT Raised to $140.00

     ETF DAILY NEWS· 6 days ago

     Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) had its price objective raised by equities researchers at Morgan Stanley from $116.00 to $140.00 in a research note issued ...

10. • Cantor Fitzgerald Research Analysts Lower Earnings Estimates for Cabaletta Bio, Inc. (NASDAQ:CABA)

      ETF DAILY NEWS· 4 days ago

      Cabaletta Bio, Inc. (NASDAQ:CABA – Free Report) – Cantor Fitzgerald lowered their FY2024 EPS estimates for shares of Cabaletta Bio in a note issued to investors on Thursday ...